BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1187 related articles for article (PubMed ID: 32002645)

  • 21. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
    Chong HH; Yang L; Sheng RF; Yu YL; Wu DJ; Rao SX; Yang C; Zeng MS
    Eur Radiol; 2021 Jul; 31(7):4824-4838. PubMed ID: 33447861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma.
    Che F; Xu Q; Li Q; Huang ZX; Yang CW; Wang LY; Wei Y; Shi YJ; Song B
    World J Gastroenterol; 2022 Apr; 28(14):1479-1493. PubMed ID: 35582676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
    Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
    Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
    Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
    Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.
    Nie P; Yang G; Guo J; Chen J; Li X; Ji Q; Wu J; Cui J; Xu W
    Cancer Imaging; 2020 Feb; 20(1):20. PubMed ID: 32093786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images.
    Wu J; Liu A; Cui J; Chen A; Song Q; Xie L
    BMC Med Imaging; 2019 Mar; 19(1):23. PubMed ID: 30866850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
    Chen Y; Chen J; Zhang Y; Lin Z; Wang M; Huang L; Huang M; Tang M; Zhou X; Peng Z; Huang B; Feng ST
    J Hepatocell Carcinoma; 2021; 8():795-808. PubMed ID: 34327180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
    Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
    Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    Chen Y; Xia Y; Tolat PP; Long L; Jiang Z; Huang Z; Tang Q
    AJR Am J Roentgenol; 2021 Jun; 216(6):1510-1520. PubMed ID: 33826360
    [No Abstract]   [Full Text] [Related]  

  • 32. Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.
    Yan M; Zhang X; Zhang B; Geng Z; Xie C; Yang W; Zhang S; Qi Z; Lin T; Ke Q; Li X; Wang S; Quan X
    Eur Radiol; 2023 Jul; 33(7):4949-4961. PubMed ID: 36786905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomics nomogram for prediction of microvascular invasion in hepatocellular carcinoma based on MR imaging with Gd-EOB-DTPA.
    Zhang S; Duan C; Zhou X; Liu F; Wang X; Shao Q; Gao Y; Duan F; Zhao R; Wang G
    Front Oncol; 2022; 12():1034519. PubMed ID: 36387156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
    Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
    BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
    Yu Y; Fan Y; Wang X; Zhu M; Hu M; Shi C; Hu C
    Eur Radiol; 2022 Feb; 32(2):959-970. PubMed ID: 34480625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
    Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
    Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
    Niu XK; He XF
    World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Potential Prognostic Marker for Recognizing VEGF-Positive Hepatocellular Carcinoma Based on Magnetic Resonance Radiomics Signature.
    Fan T; Li S; Li K; Xu J; Zhao S; Li J; Zhou X; Jiang H
    Front Oncol; 2022; 12():857715. PubMed ID: 35444942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
    AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.